Frank L.

Frank L. has a wealth of experience in the scientific field. Frank began their career in 2008 as a Postdoctoral Researcher and a PHD Researcher at the HelmholtzZentrum M\u00fcnchen. In 2013, they moved to the Universit\u00e4ts-Kinderspital beider Basel / Department of Biomedicine Basel, where they held the role of Postdoctoral Researcher. Frank'sresearch topics included Microbiota-induced tissue signals regulating ILC3-mediated antigen presentation, analysis of the role of pancreatic ILC2 in type 2 diabetes, and tumor recognition strategies of innate lymphoid cells. Frank was also responsible for project development and gathering of external funding, performing experiments, writing of scientific publications, presentation of scientific data, and guidance of technical assistants and students. In 2022, Frank L. moved to Cimeio Therapeutics, where they currently hold the role of Senior Scientist Preclinical Models.

Frank L. completed a Certificate in Statistics and R from HarvardX in 2020. From 2012 to 2013, they attended Berlin University for Professional Studies, earning a Universitätszertifikat in Pharmaceutical Basics of Drug Development. From 2008 to 2012, they attended Ludwig-Maximilians-Universität München, earning a Doctor of Philosophy (PhD) in Biology/Immunology. Finally, from 2003 to 2008, they attended Bielefeld University, earning a Diploma in Molecular Biotechnology.